Evidence map›Paper›PMID 32344532›Full record

ReviewInternational journal of molecular sciences2020

Naltrexone Use in Treating Hypersexuality Induced by Dopamine Replacement Therapy: Impact of

Audrey Verholleman, Caroline Victorri-Vigneau, Edouard Laforgue, Pascal Derkinderen, Celine Verstuyft, Marie Grall-Bronnec

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Audrey VerhollemanAddictology and Psychiatry Department, CHU Nantes, 44093 Nantes, France.
Caroline Victorri-VigneauInserm UMR-1246, Université de Nantes, Université de Tours, 44200 Nantes, France.
Edouard LaforgueAddictology and Psychiatry Department, CHU Nantes, 44093 Nantes, France.
Pascal DerkinderenNeurology Department, CHU Nantes, 44093 Nantes, France.
Celine VerstuyftInserm UMR-1178, CESP, Université Paris-Sud, 94276 Le Kremlin Bicêtre, France.
Marie Grall-BronnecAddictology and Psychiatry Department, CHU Nantes, 44093 Nantes, France.
Université de Tours · FRCentre d'Investigation Clinique de Nantes · FRInserm · FRUniversité Paris-Sud · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypersexuality is a well-known adverse side effect of dopamine replacement therapy (DRT), and anti-craving drugs could be an effective therapeutic option. Our aim was to update the knowledge on this issue, particularly on the influence of an Opioid Receptor Mu 1 (

Indexed as

Disease SusceptibilityAnimalsDopamineGenetic Predisposition to DiseaseGenotypeHumansNaltrexoneNarcotic AntagonistsParkinson DiseasePolymorphism, Single NucleotideReceptors, Opioid, muSexual Dysfunction, PhysiologicalSexualityTreatment OutcomeDopamineNaltrexoneNarcotic AntagonistsOPRM1 protein, humanReceptors, Opioid, mudopamine replacement therapygenotypinghypersexualityimpulse control disordernaltrexoneOPRM1Parkinson’s diseasesex addiction

Identifiers

PMID32344532
PMCPMC7215378
OpenAlexW3020034886

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.